Physician profile
John J Nelson
NPI 1376540005
$506.40
in general payments reported to CMS, 2019-2025
9 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $71.45 · 2022: $17.17 · 2023: $20.04 · 2024: $16.58 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $182.02 | 2019 | |
| Glaxosmithkline, LLC. | $108.07 | 2020-2024 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $46.91 | 2025 | |
| Vanda Pharmaceuticals INC. | $44.41 | 2025 | Fanapt |
| Lilly USA, LLC | $44.41 | 2025 | Zepbound, Mounjaro |
| Baxter Healthcare | $25.90 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Exact Sciences Corporation | $22.97 | 2025 | |
| Novo Nordisk INC | $17.17 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.54 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.